Literature DB >> 11741204

Kinetics of hallmark biochemical changes in paclitaxel-induced apoptosis.

J L Au1, R R Kumar, D Li, M G Wientjes.   

Abstract

Apoptosis is associated with cascades of biochemical changes, including caspase activation, cleavage of poly-ADP-ribose polymerase (PARP), and fragmentation of genomic DNA. Knowledge of the kinetics of these changes in drug-induced apoptosis is important for designing pharmacodynamic studies. We have shown that the slow manifestation of apoptosis contributes to the delayed pharmacological effects of paclitaxel (Cancer Res. 58:2141-2148, 1998). The present study examined the timing of the biochemical changes in paclitaxel-induced apoptosis in human prostate PC3 cancer cells. After treatment with 20 nM paclitaxel, the fraction of cells that detached from the culture flask increased with time to reach 68% at the end of the 96-hour experiment. In contrast, the control samples showed <1% detachment. The attached and detached paclitaxel-treated cells showed different biochemical properties. The detached cells exhibited the full spectrum of apoptotic changes, whereas the attached cells only showed activation of caspase-3-like proteases but not PARP cleavage, DNA fragmentation, nor release of DNA fragments to the cytoplasm. Activation of caspases in the attached cells was several-fold lower and occurred at a later time (ie, 24 vs 12 hours) compared to the detached cells. In the detached cells, caspase activation was first detected at 12 hours and peaked at 36 hours, whereas PARP cleavage was first detected at 24 hours and was completed prior to 72 hours. In contrast, the extent of internucleosomal DNA fragmentation and the release of DNA-histone complex to the cytoplasm (both were first detected at 24 hours) were cumulative over time up to the last time point of 96 hours. In summary, in paclitaxel-induced apoptosis, caspase activation was followed with a 12-hour lag time by PARP cleavage, internucleosomal DNA fragmentation, and release of DNA-histone complex to the cytoplasm. There was no detectable lag time between PARP cleavage and DNA fragmentation. The observation that only the detached cells but not the attached cells showed the full spectrum of apoptotic changes suggests that detachment is either a part of the initiation/execution phases of apoptosis and/or is required for their completion.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 11741204      PMCID: PMC2761122          DOI: 10.1208/ps010308

Source DB:  PubMed          Journal:  AAPS PharmSci        ISSN: 1522-1059


  26 in total

1.  Degradation of lamin B1 precedes oligonucleosomal DNA fragmentation in apoptotic thymocytes and isolated thymocyte nuclei.

Authors:  N Neamati; A Fernandez; S Wright; J Kiefer; D J McConkey
Journal:  J Immunol       Date:  1995-04-15       Impact factor: 5.422

2.  Apoptosis. The role of the endonuclease.

Authors:  M J Arends; R G Morris; A H Wyllie
Journal:  Am J Pathol       Date:  1990-03       Impact factor: 4.307

3.  Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation.

Authors:  A H Wyllie
Journal:  Nature       Date:  1980-04-10       Impact factor: 49.962

4.  Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE.

Authors:  Y A Lazebnik; S H Kaufmann; S Desnoyers; G G Poirier; W C Earnshaw
Journal:  Nature       Date:  1994-09-22       Impact factor: 49.962

5.  Taxol induces internucleosomal DNA fragmentation associated with programmed cell death in human myeloid leukemia cells.

Authors:  K Bhalla; A M Ibrado; E Tourkina; C Tang; M E Mahoney; Y Huang
Journal:  Leukemia       Date:  1993-04       Impact factor: 11.528

6.  Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis.

Authors:  S H Kaufmann; S Desnoyers; Y Ottaviano; N E Davidson; G G Poirier
Journal:  Cancer Res       Date:  1993-09-01       Impact factor: 12.701

7.  Activation of intracellular proteases is an early event in TNF-induced apoptosis.

Authors:  C Voelkel-Johnson; A J Entingh; W S Wold; L R Gooding; S M Laster
Journal:  J Immunol       Date:  1995-02-15       Impact factor: 5.422

8.  Taxol stabilizes microtubules in mouse fibroblast cells.

Authors:  P B Schiff; S B Horwitz
Journal:  Proc Natl Acad Sci U S A       Date:  1980-03       Impact factor: 11.205

9.  Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.

Authors:  Y Gavrieli; Y Sherman; S A Ben-Sasson
Journal:  J Cell Biol       Date:  1992-11       Impact factor: 10.539

10.  Disruption of epithelial cell-matrix interactions induces apoptosis.

Authors:  S M Frisch; H Francis
Journal:  J Cell Biol       Date:  1994-02       Impact factor: 10.539

View more
  11 in total

Review 1.  Improving delivery and efficacy of nanomedicines in solid tumors: role of tumor priming.

Authors:  Jie Wang; Ze Lu; Yue Gao; M Guillaume Wientjes; Jessie L-S Au
Journal:  Nanomedicine (Lond)       Date:  2011-11       Impact factor: 5.307

2.  Metabolic oligosaccharide engineering with N-Acyl functionalized ManNAc analogs: cytotoxicity, metabolic flux, and glycan-display considerations.

Authors:  Ruben T Almaraz; Udayanath Aich; Hargun S Khanna; Elaine Tan; Rahul Bhattacharya; Shivam Shah; Kevin J Yarema
Journal:  Biotechnol Bioeng       Date:  2011-11-21       Impact factor: 4.530

3.  Dynamic monitoring of apoptosis in chemotherapies with multiple fluorescence reporters.

Authors:  Yunlong Li; Da Xing; Qun Chen
Journal:  Mol Imaging Biol       Date:  2009-01-09       Impact factor: 3.488

4.  Determinants of paclitaxel uptake, accumulation and retention in solid tumors.

Authors:  S H Jang; M G Wientjes; J L Au
Journal:  Invest New Drugs       Date:  2001-05       Impact factor: 3.850

5.  Pharmacodynamics of telomerase inhibition and telomere shortening by noncytotoxic suramin.

Authors:  Yuebo Gan; Jie Lu; Bertrand Z Yeung; Christopher T Cottage; M Guillaume Wientjes; Jessie L-S Au
Journal:  AAPS J       Date:  2014-11-26       Impact factor: 4.009

6.  Temporal Effects of Combined Birinapant and Paclitaxel on Pancreatic Cancer Cells Investigated via Large-Scale, Ion-Current-Based Quantitative Proteomics (IonStar).

Authors:  Xue Wang; Jin Niu; Jun Li; Xiaomeng Shen; Shichen Shen; Robert M Straubinger; Jun Qu
Journal:  Mol Cell Proteomics       Date:  2018-01-22       Impact factor: 5.911

7.  Mechanism-based mathematical modeling of combined gemcitabine and birinapant in pancreatic cancer cells.

Authors:  Xu Zhu; Robert M Straubinger; William J Jusko
Journal:  J Pharmacokinet Pharmacodyn       Date:  2015-08-08       Impact factor: 2.745

Review 8.  Drug delivery and transport to solid tumors.

Authors:  Seong Hoon Jang; M Guillaume Wientjes; Dan Lu; Jessie L S Au
Journal:  Pharm Res       Date:  2003-09       Impact factor: 4.200

9.  Systems pharmacological analysis of paclitaxel-mediated tumor priming that enhances nanocarrier deposition and efficacy.

Authors:  Sihem Ait-Oudhia; Robert M Straubinger; Donald E Mager
Journal:  J Pharmacol Exp Ther       Date:  2012-10-31       Impact factor: 4.030

10.  Menadione : sodium orthovanadate combination eliminates and inhibits migration of detached cancer cells.

Authors:  Zahid M Delwar; Ake Siden; Mabel H Cruz; Juan S Yakisich
Journal:  ISRN Pharmacol       Date:  2012-08-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.